Cargando…

Ophthalmic manifestations in patients with inflammatory bowel disease: A review

Clinical manifestations of inflammatory bowel disease (IBD) are not locally restricted to the gastrointestinal tract, and a significant portion of patients have involvement of other organs and systems. The visual system is one of the most frequently affected, mainly by inflammatory disorders such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Troncoso, Leandro Lopes, Biancardi, Ana Luiza, de Moraes Jr, Haroldo Vieira, Zaltman, Cyrla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583569/
https://www.ncbi.nlm.nih.gov/pubmed/28932076
http://dx.doi.org/10.3748/wjg.v23.i32.5836
_version_ 1783261341851582464
author Troncoso, Leandro Lopes
Biancardi, Ana Luiza
de Moraes Jr, Haroldo Vieira
Zaltman, Cyrla
author_facet Troncoso, Leandro Lopes
Biancardi, Ana Luiza
de Moraes Jr, Haroldo Vieira
Zaltman, Cyrla
author_sort Troncoso, Leandro Lopes
collection PubMed
description Clinical manifestations of inflammatory bowel disease (IBD) are not locally restricted to the gastrointestinal tract, and a significant portion of patients have involvement of other organs and systems. The visual system is one of the most frequently affected, mainly by inflammatory disorders such as episcleritis, uveitis and scleritis. A critical review of available literature concerning ocular involvement in IBD, as it appears in PubMed, was performed. Episcleritis, the most common ocular extraintestinal manifestation (EIM), seems to be more associated with IBD activity when compared with other ocular EIMs. In IBD patients, anterior uveitis has an insidious onset, it is longstanding and bilateral, and not related to the intestinal disease activity. Systemic steroids or immunosuppressants may be necessary in severe ocular inflammation cases, and control of the underlying bowel disease is important to prevent recurrence. Our review revealed that ocular involvement is more prevalent in Crohn’s disease than ulcerative colitis, in active IBD, mainly in the presence of other EIMs. The ophthalmic symptoms in IBD are mainly non-specific and their relevance may not be recognized by the clinician; most ophthalmic manifestations are treatable, and resolve without sequel upon prompt treatment. A collaborative clinical care team for management of IBD that includes ophthalmologists is central for improvement of quality care for these patients, and it is also cost-effective.
format Online
Article
Text
id pubmed-5583569
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-55835692017-09-20 Ophthalmic manifestations in patients with inflammatory bowel disease: A review Troncoso, Leandro Lopes Biancardi, Ana Luiza de Moraes Jr, Haroldo Vieira Zaltman, Cyrla World J Gastroenterol Review Clinical manifestations of inflammatory bowel disease (IBD) are not locally restricted to the gastrointestinal tract, and a significant portion of patients have involvement of other organs and systems. The visual system is one of the most frequently affected, mainly by inflammatory disorders such as episcleritis, uveitis and scleritis. A critical review of available literature concerning ocular involvement in IBD, as it appears in PubMed, was performed. Episcleritis, the most common ocular extraintestinal manifestation (EIM), seems to be more associated with IBD activity when compared with other ocular EIMs. In IBD patients, anterior uveitis has an insidious onset, it is longstanding and bilateral, and not related to the intestinal disease activity. Systemic steroids or immunosuppressants may be necessary in severe ocular inflammation cases, and control of the underlying bowel disease is important to prevent recurrence. Our review revealed that ocular involvement is more prevalent in Crohn’s disease than ulcerative colitis, in active IBD, mainly in the presence of other EIMs. The ophthalmic symptoms in IBD are mainly non-specific and their relevance may not be recognized by the clinician; most ophthalmic manifestations are treatable, and resolve without sequel upon prompt treatment. A collaborative clinical care team for management of IBD that includes ophthalmologists is central for improvement of quality care for these patients, and it is also cost-effective. Baishideng Publishing Group Inc 2017-08-28 2017-08-28 /pmc/articles/PMC5583569/ /pubmed/28932076 http://dx.doi.org/10.3748/wjg.v23.i32.5836 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Review
Troncoso, Leandro Lopes
Biancardi, Ana Luiza
de Moraes Jr, Haroldo Vieira
Zaltman, Cyrla
Ophthalmic manifestations in patients with inflammatory bowel disease: A review
title Ophthalmic manifestations in patients with inflammatory bowel disease: A review
title_full Ophthalmic manifestations in patients with inflammatory bowel disease: A review
title_fullStr Ophthalmic manifestations in patients with inflammatory bowel disease: A review
title_full_unstemmed Ophthalmic manifestations in patients with inflammatory bowel disease: A review
title_short Ophthalmic manifestations in patients with inflammatory bowel disease: A review
title_sort ophthalmic manifestations in patients with inflammatory bowel disease: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583569/
https://www.ncbi.nlm.nih.gov/pubmed/28932076
http://dx.doi.org/10.3748/wjg.v23.i32.5836
work_keys_str_mv AT troncosoleandrolopes ophthalmicmanifestationsinpatientswithinflammatoryboweldiseaseareview
AT biancardianaluiza ophthalmicmanifestationsinpatientswithinflammatoryboweldiseaseareview
AT demoraesjrharoldovieira ophthalmicmanifestationsinpatientswithinflammatoryboweldiseaseareview
AT zaltmancyrla ophthalmicmanifestationsinpatientswithinflammatoryboweldiseaseareview